CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,842,729 | -18.7% | 1,538,725 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $85,955,392 | +28.0% | 1,531,090 | +3.1% | 0.00% | 0.0% |
| Q1 2023 | $67,147,056 | +14.5% | 1,484,569 | +2.9% | 0.00% | 0.0% |
| Q4 2022 | $58,628,560 | -37.5% | 1,442,277 | +0.5% | 0.00% | -33.3% |
| Q3 2022 | $93,803,000 | +16.7% | 1,435,410 | +8.5% | 0.00% | +50.0% |
| Q2 2022 | $80,407,000 | +5.2% | 1,323,141 | +8.7% | 0.00% | 0.0% |
| Q1 2022 | $76,410,000 | +199.4% | 1,217,289 | +261.4% | 0.00% | +100.0% |
| Q4 2021 | $25,525,000 | -36.7% | 336,826 | -6.6% | 0.00% | 0.0% |
| Q3 2021 | $40,355,000 | -5.5% | 360,541 | +36.7% | 0.00% | 0.0% |
| Q2 2021 | $42,700,000 | +34.9% | 263,758 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $31,643,000 | -17.4% | 259,697 | +3.8% | 0.00% | 0.0% |
| Q4 2020 | $38,299,000 | +17.3% | 250,140 | -35.9% | 0.00% | 0.0% |
| Q3 2020 | $32,655,000 | +33.2% | 390,424 | +17.0% | 0.00% | 0.0% |
| Q2 2020 | $24,513,000 | +211.1% | 333,554 | +79.6% | 0.00% | – |
| Q1 2020 | $7,879,000 | -24.0% | 185,772 | +9.2% | 0.00% | – |
| Q4 2019 | $10,362,000 | +207.9% | 170,135 | +107.3% | 0.00% | – |
| Q3 2019 | $3,365,000 | -12.0% | 82,091 | +1.1% | 0.00% | – |
| Q2 2019 | $3,822,000 | +66.3% | 81,159 | +26.1% | 0.00% | – |
| Q1 2019 | $2,298,000 | +33.9% | 64,338 | +7.1% | 0.00% | – |
| Q4 2018 | $1,716,000 | -25.6% | 60,055 | +15.4% | 0.00% | – |
| Q3 2018 | $2,307,000 | -19.6% | 52,023 | +6.6% | 0.00% | – |
| Q2 2018 | $2,869,000 | +51.8% | 48,823 | +18.1% | 0.00% | – |
| Q1 2018 | $1,890,000 | +366.7% | 41,344 | +139.4% | 0.00% | – |
| Q4 2017 | $405,000 | +31.1% | 17,268 | -0.1% | 0.00% | – |
| Q3 2017 | $309,000 | +13.2% | 17,283 | +1.6% | 0.00% | – |
| Q2 2017 | $273,000 | – | 17,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |